FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386879214> ?p ?o ?g. }

• W4386879214 endingPage "2908" @default.
• W4386879214 startingPage "2899" @default.
• W4386879214 abstract "Itraconazole follows non-linear pharmacokinetics and hence is recommended once daily, but in real-world practice, is commonly prescribed as twice daily. Hence, this study aimed to evaluate the efficacy and safety of super-bioavailable-itraconazole-130 mg (SB-130) and conventional-itraconazole-200 mg (CITZ-200) once daily compared with conventional-itraconazole-100 mg (CITZ-100) twice daily in glabrous tinea.A total of 261 eligible patients were enrolled in this prospective, randomized, clinical study from December-2021 to August-2022 at seven centers in India. Efficacy and safety assessments were done at week-3 and 6, with follow-up at week-10 for relapse. The primary objective was to assess the proportion of patients who achieved complete cure at week-6 following treatment in all itraconazole groups. The secondary outcomes were safety and clinical and mycological cure rates.Of 261 patients, 240 were included in the analysis. At week-6, 140 patients were completely cured; thus, overall cure rate was 58.33%. Fifty-five patients (69%) in SB-130 while 47/77 (61%) and 38/83 (46%) patients were completely cured in CITZ-200 and CITZ-100 groups respectively (p<0.05; SB-130: CITZ-100, p=0.32; SB-130: CITZ-200, p=0.058; CITZ-200: CITZ-100). There was no statistical difference in the mycological cure rate and area clearance rate between any of the groups (p=0.14); however, a statistically significant difference was noted for OD dosing over BD dosing in achieving clinical cure rates (p<0.05). A total of 13/140 patients (9%) relapsed following complete cure, with no statistically significant difference between any of the groups (p=0.50). All treatments were safe and well-tolerated, with no discontinuation.In this clinical study, moderate efficacy with all doses of ITZ was reported but was better with OD dosing. Although there was no statistical difference between SB-130 and CITZ-200, SB-130 may be preferred over CITZ-200 owing to the advantage of SB over the conventional ITZ." @default.
• W4386879214 created "2023-09-21" @default.
• W4386879214 creator A5004187445 @default.
• W4386879214 creator A5004329283 @default.
• W4386879214 creator A5010300660 @default.
• W4386879214 creator A5011447590 @default.
• W4386879214 creator A5017052127 @default.
• W4386879214 creator A5032330467 @default.
• W4386879214 creator A5034284364 @default.
• W4386879214 creator A5039592421 @default.
• W4386879214 creator A5045833523 @default.
• W4386879214 creator A5051710377 @default.
• W4386879214 creator A5055416313 @default.
• W4386879214 creator A5069436933 @default.
• W4386879214 creator A5070489582 @default.
• W4386879214 creator A5071878091 @default.
• W4386879214 creator A5072289407 @default.
• W4386879214 creator A5078695710 @default.
• W4386879214 creator A5089535952 @default.
• W4386879214 creator A5091172284 @default.
• W4386879214 creator A5091795157 @default.
• W4386879214 date "2023-09-01" @default.
• W4386879214 modified "2023-10-05" @default.
• W4386879214 title "Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial" @default.
• W4386879214 cites W13726000 @default.
• W4386879214 cites W1773516461 @default.
• W4386879214 cites W1970634889 @default.
• W4386879214 cites W1971920484 @default.
• W4386879214 cites W1981516536 @default.
• W4386879214 cites W1989617949 @default.
• W4386879214 cites W2002752367 @default.
• W4386879214 cites W2005891936 @default.
• W4386879214 cites W2043527252 @default.
• W4386879214 cites W2069193583 @default.
• W4386879214 cites W2080865258 @default.
• W4386879214 cites W2107564745 @default.
• W4386879214 cites W2110078378 @default.
• W4386879214 cites W2112091988 @default.
• W4386879214 cites W2151464620 @default.
• W4386879214 cites W2756050792 @default.
• W4386879214 cites W2788080791 @default.
• W4386879214 cites W2801369439 @default.
• W4386879214 cites W2883897465 @default.
• W4386879214 cites W2896452734 @default.
• W4386879214 cites W2951150727 @default.
• W4386879214 cites W2963118445 @default.
• W4386879214 cites W2964737468 @default.
• W4386879214 cites W3007140142 @default.
• W4386879214 cites W3028394492 @default.
• W4386879214 cites W3035761775 @default.
• W4386879214 cites W3080407494 @default.
• W4386879214 cites W3130086869 @default.
• W4386879214 cites W3153123200 @default.
• W4386879214 cites W3162533950 @default.
• W4386879214 cites W3165697746 @default.
• W4386879214 cites W3189204461 @default.
• W4386879214 cites W3200991177 @default.
• W4386879214 cites W3202329215 @default.
• W4386879214 cites W4295681901 @default.
• W4386879214 cites W4313567960 @default.
• W4386879214 doi "https://doi.org/10.2147/dddt.s421583" @default.
• W4386879214 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37766823" @default.
• W4386879214 hasPublicationYear "2023" @default.
• W4386879214 type Work @default.
• W4386879214 citedByCount "0" @default.
• W4386879214 crossrefType "journal-article" @default.
• W4386879214 hasAuthorship W4386879214A5004187445 @default.
• W4386879214 hasAuthorship W4386879214A5004329283 @default.
• W4386879214 hasAuthorship W4386879214A5010300660 @default.
• W4386879214 hasAuthorship W4386879214A5011447590 @default.
• W4386879214 hasAuthorship W4386879214A5017052127 @default.
• W4386879214 hasAuthorship W4386879214A5032330467 @default.
• W4386879214 hasAuthorship W4386879214A5034284364 @default.
• W4386879214 hasAuthorship W4386879214A5039592421 @default.
• W4386879214 hasAuthorship W4386879214A5045833523 @default.
• W4386879214 hasAuthorship W4386879214A5051710377 @default.
• W4386879214 hasAuthorship W4386879214A5055416313 @default.
• W4386879214 hasAuthorship W4386879214A5069436933 @default.
• W4386879214 hasAuthorship W4386879214A5070489582 @default.
• W4386879214 hasAuthorship W4386879214A5071878091 @default.
• W4386879214 hasAuthorship W4386879214A5072289407 @default.
• W4386879214 hasAuthorship W4386879214A5078695710 @default.
• W4386879214 hasAuthorship W4386879214A5089535952 @default.
• W4386879214 hasAuthorship W4386879214A5091172284 @default.
• W4386879214 hasAuthorship W4386879214A5091795157 @default.
• W4386879214 hasBestOaLocation W43868792141 @default.
• W4386879214 hasConcept C112705442 @default.
• W4386879214 hasConcept C126322002 @default.
• W4386879214 hasConcept C141071460 @default.
• W4386879214 hasConcept C16005928 @default.
• W4386879214 hasConcept C168563851 @default.
• W4386879214 hasConcept C2777071850 @default.
• W4386879214 hasConcept C2777288759 @default.
• W4386879214 hasConcept C2779548794 @default.
• W4386879214 hasConcept C2994123057 @default.
• W4386879214 hasConcept C535046627 @default.
• W4386879214 hasConcept C71924100 @default.
• W4386879214 hasConceptScore W4386879214C112705442 @default.

• next